We previously identified and characterized a novel TWIST1 inhibitor, harmine, that degrades TWIST1, inhibits multiple TWIST1-dependent functions, and results in growth inhibition in oncogene-driven NSCLC [26, 27]. The gene discussed is TWIST1; the disease is non-small cell lung carcinoma.